Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty

Completed

Conditions studied: Hip Osteoarthritis

In brief

Monitor the performance of the Mpact cup in the treatment of patients with hip joint disease requiring a total hip replacement.

Key facts

Study ID

NCT03897595

Run by

Medacta USA

People needed

187

Starts

2012-10-01

Expected to finish

2022-03-30

Last updated by the study team

2023-06-18

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery.
• Those presenting with disease that meets the indications for use for Medacta USA implants defined by this study (on-label use).
• Patients must be willing to comply with the pre and post-operative evaluation schedule

You may not qualify if…

• Those with one or more medical conditions identified as a contraindication defined by the labeling on any Medacta implants used in this study.

Where it is running

• Denver Vail Orthopedics — Parker, Colorado, United States
• Saint Alphonsus Medical Group — Boise, Idaho, United States
• Illinois Bone and Joint Institute — Libertyville, Illinois, United States
• McBride Orthopedic Hospital — Oklahoma City, Oklahoma, United States
• Jordan Valley Medical Center of Orthopedics Rehabilitation and Excellence — West Jordan, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.